518 Studies indicate that liraglutide may inhibit liver carcinogenesis through its metabolic effects, suggesting that GLP-1RAs could potentially play a role in preventing or managing HCC in the context of NASH
Wegovy is approved for chronic weight management at a higher dose
To understand why constipation occurs, we need to examine how GLP-1 receptor agonists function
These pharmacies verify potency, sterility, and purity before dispensing
GLP-1 agonism: Emerging hypotheses and limitations While GLP-1 RAs hold therapeutic promise for increasing lifespan and reducing the morbidity of age-related illness through action on multiple organ systems, tissue-specific effects of GLP-1R agonism are possible
Probiotic recommendations for GLP-1 agonist users apply well here, though the glucagon receptor component of retatrutide may create somewhat different microbiome changes than pure GLP-1 agonists